drugset / Trial / NCT05848635
Hydromorphone for Perioperative Analgesia in Lung Tumor Ablation Parallel Controlled
RandomizedParallel-groupDouble-blindTreatment
Summary
This randomized, parallel controlled, single blind trial is designed to evaluate the efficacy and safety of hydromorphone versus morphine for perioperative analgesia in lung tumor ablation.
Timeline
- Start
- 2023-05-01
- Primary completion
- 2024-05-01
- Completion
- 2024-05-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Hydromorphone | Other / unclassified | 2 mg | Subcutaneous |
| Comparator | Morphine | Other / unclassified | 10 mg | Subcutaneous |